Product Addendum for Mail-Order Sales and Delivery of Over-the-Counter Medicines
Poland
Addendum Effective Date: April 27, 2026
This product addendum for mail-order sales and delivery of over-the-counter medicines (“Medicines Addendum”) is incorporated into the Agreement and forms an integral part of the Merchant Services Agreement. This Medicines Addendum prevails over any other Product Addendum for deliveries of medicinal products. All capitalized terms used and not defined herein shall have the meanings ascribed to them in the Sign-Up Sheet, the General Terms of Service for Merchants, the Marketplace Addendum or the Drive Addendum.
1. THE MERCHANT’S RIGHTS AND RESPONSIBILITIES
1.1 The Wolt Service may be used by the Merchant for the purpose of selling over-the-counter medicines (“OTC medicines”) subject to the Merchant having signed the Marketplace Addendum and subject to the Merchant’s compliance with this Medicines Addendum. The Merchant shall not offer or sell prescription medicines or products containing psychoactive substances in the Wolt Service.
1.2 Wolt’s Drive Services may be used by the Merchant for the purpose of delivering OTC medicines sold in the Merchant’s own point of sale outside of the Wolt Service subject to the Merchant having signed the Drive Addendum and subject to the Merchant’s compliance with this Medicines Addendum.
1.3 The Merchant is solely responsible for holding all legally required registrations, permits and authorizations for the mail-order sales of OTC medicines. To the extent the Merchant intends to sell OTC medicines in the Wolt Service, the Merchant shall ensure that said registrations, permits and authorizations apply also with respect to carrying out online sales of OTC medicines in the Wolt Service, as provided for in applicable laws on mail-order dispensing of medicinal products.
1.4 Prior to adding OTC medicines to the Merchant’s selection in the Wolt Service, the Merchant is responsible for notifying the State Pharmaceutical Inspection of its intention to sell OTC medicines in the Wolt Service. In the notification, the Merchant shall include any required information, including the Merchant’s URL address for the Merchant’s dedicated venue page within the Wolt Service. The Merchant must ensure that its dedicated venue page is listed in the authority’s publicly available register for online pharmacies for the entire duration that the Merchant engages in online sales of OTC medicines in the Wolt Service and that the Merchant notifies the authority of any changes to the information provided to the authority concerning the Merchant’s online sales of OTC medicines in the Wolt Service.
1.5 The Merchant is solely responsible for carrying out online sales of OTC medicines in the Wolt Service in compliance with applicable laws and authority guidance, including providing any necessary medical advice to Users and for providing Users with the possibility of telephone contact during the Merchant’s opening hours and for two hours after the available delivery hours regarding the quality and safety of the medicinal products sold by mail-order. The Merchant shall notify Wolt without delay of any regulatory changes or authority guidance that impact the online sale or delivery of medicinal products in a manner that may also affect Wolt’s responsibilities or the Wolt Service.
1.6 The Merchant shall ensure that the Merchant Content in the Wolt Service concerning the Merchant and OTC medicines complies with applicable laws, is complete and is kept up-to-date. The Merchant shall further ensure that Users are informed about mandatory information required to be given in connection with online sales of OTC medicines in the Wolt Service, such as but not limited to the range of OTC medicines offered and their final price. To the extent necessary to ensure compliance, the Merchant shall provide Wolt with all information required to be displayed on the Merchant’s venue page in the Wolt Service.
1.7 The Merchant may, at its discretion, use an order management system other than the Wolt Merchant App to receive and process orders, provided that the system is integrated with the Wolt Service in a manner approved by Wolt. Wolt does not cover the costs of implementing or maintaining that integration. Wolt does not warrant or guarantee, and is not responsible for, the availability, performance, or functioning of the Merchant’s order management system or the integration between that system and the Wolt Service, including any implementation by a third party.
1.8 The Merchant shall package OTC medicines for delivery by Wolt’s courier partners in a manner that ensures the preservation of their quality and is otherwise appropriate considering the nature of the OTC medicines, prevailing weather conditions and the Merchant’s risk assessment. The packaging must be sealed to prevent any unauthorized access to the OTC medicines during delivery. The Merchant must include inside the packaging any written order confirmation or instructions required to be provided to Users about the OTC medicines they have purchased. The Merchant must also ensure that any information required to be visible on the outside of the packaging is included.
1.9 The Merchant shall not use Wolt’s Products for delivering medicines which require a delivery temperature below 8 °C, unless separately agreed in writing.
1.10 The Merchant has the right to audit Wolt's compliance with Wolt’s obligations under this Medicines Addendum. The Merchant may also conduct delivery temperature monitoring using the Merchant’s own temperature sensors. Any audit and temperature monitoring shall be conducted in a way that it causes as little disruption to Wolt’s operations as reasonably possible and by notifying Wolt in advance. The Merchant is responsible for covering any costs of an audit or temperature monitoring. Any findings from such audits or temperature monitoring shall be shared with Wolt. If the Merchant identifies any material non-compliance, Wolt shall review the findings in good faith and, where reasonably required and feasible, take appropriate corrective actions. For clarity, nothing in this Addendum obligates Wolt to adopt changes that are not operationally feasible or that fall outside the scope of Wolt’s obligations under this Medicines Addendum.
1.11 The Merchant is solely responsible for establishing and keeping any order record required under applicable law in connection with the sale of medicinal products. During the Agreement, Wolt will store the relevant order information in the Wolt Merchant Admin portal and make it available to the Merchant. That information is: (a) what Wolt receives via the order flow, and (b) any additional information, such as batch information, the Merchant sends (or integrator sends on the Merchant’s behalf) to Wolt after dispatch through the integration used by the Merchant. Wolt will present this information using the data fields, layout and technical capabilities that Wolt determines and supports in its reasonable discretion from time to time. Upon termination or expiry of the Agreement, the Parties will agree separately on further handling, export, and storing of the information, subject to applicable law.
2. WOLT’S RIGHTS AND RESPONSIBILITIES
2.1 Subject to the Merchant having concluded a sub-license agreement on the use of the EU common logo for legally operating online pharmacies/retailers, Wolt shall ensure that said logo will be displayed on the Merchant’s venue page in the Wolt Service, to the extent the Merchant sells OTC medicines in the Wolt Service.
2.2 Wolt shall ensure that OTC medicines are delivered in thermally insulated delivery bags or other appropriate transport containers and within delivery temperature ranges specified by the Merchant. Wolt shall further ensure that medicines are not exposed to harmful external conditions, such as heat, cold, moisture, direct sunlight or physical impacts during delivery. Wolt shall ensure that courier partners shall not open medicine packages being delivered and shall not leave medicine packages unattended prior to hand-over to the recipient.
2.3 If Wolt receives a notification from a User, or otherwise becomes aware, that a package containing OTC medicines has been left unattended or has been exposed to harmful external conditions, Wolt will report such an incident to the Merchant without delay, and if hand-over has not yet happened, will not hand over the package to the User. Wolt shall follow any instructions provided by the Merchant in such a situation, to the extent operationally feasible and lawful, including returning the package to the Merchant if required.
2.4 Wolt shall ensure that courier partners delivering OTC medicines are aware of and shall comply with the requirements of this Medicines Addendum. Wolt shall maintain systems enabling active tracking and retrospective tracing of relevant delivery information allowing Wolt to verify and report to the Merchant upon demand the pick-up and delivery times of OTC medicines.
2.5 Wolt offers a pin-code based solution as identity verification for ensuring that the medicine package is handed over to the same person who placed the order. To the extent the Merchant wishes to take said solution into use, the Merchant shall notify Wolt thereof. Said notification shall be done for Marketplace Services in connection with providing other product information for sold OTC medicines and for Drive Services by categorizing the order correctly via the Wolt Drive API or Wolt Drive Web interface. If the Merchant fails to notify Wolt appropriately, Wolt will not be liable for any regulatory non-compliance resulting from that failure.
3. RETURN OF MEDICINES
3.1 The Merchant shall provide Users with the possibility to return any medicines claimed to be damaged or non-compliant without the Users having to incur any costs for the return. Wolt shall forward any such claims received by Wolt to the Merchant.
3.2 In case a delivery of medicines cannot be completed due to the recipient not being present at the delivery address or for other reasons, Wolt shall be responsible for delivering the medicines back to the Merchant’s physical location in accordance with the applicable Product Addendum. To the extent provided for in the Agreement, Wolt may charge additional fees from the Merchant for such a return trip.
4. PROMOTIONS
4.1 Wolt’s right to offer promotional discounts at Wolt’s cost to Users on products sold by the Merchant in the Wolt Service shall not apply to OTC medicines to the extent prohibited under applicable laws.The Merchant shall be responsible for the lawfulness of any Campaigns, advertisements or promotional discounts applied or published by the Merchant or by Wolt at the Merchant’s request.
5. CONFIDENTIALITY AND DATA PRIVACY
5.1 Wolt shall not disclose to third parties, other than to Wolt Affiliates, courier partners and technical service providers to the extent necessary to meet Wolt’s contractual obligations, any medical information of Users or recipients of medicines that Wolt receives in connection with providing Services under this Medicines Addendum. Wolt shall ensure that Wolt Affiliates, courier partners and technical service providers are bound by equivalent levels of confidentiality obligations. Notwithstanding the above, Wolt may disclose such information to the extent required by applicable law, court order, or binding request of a competent regulatory or supervisory authority. This confidentiality obligation shall survive termination of the Agreement without limitation in time.
5.2 The Agreement covers processing of Personal Data by the Parties. The Parties acknowledge that orders that include medicines contain health information defined as special categories of data under the GDPR, and agree to comply with applicable laws concerning the processing of such data, and to keep such data secure and confidential.
5.3 Wolt will provide Personal Data related to sales of OTC medicines in Wolt Service to Merchant to enable the performance of the Merchant’s obligations relating to the sold products, including but not limited to the Merchant’s legal responsibilities and other obligations related to the sales of medicines. Wolt transfers the data to the Merchant and keeps it available either through Wolt’s portal available to Merchants or by other suitable technical means separately agreed between the Parties. The User may also provide Personal Data independently and directly to the Merchant through the Wolt Service or by other means.
5.4 When processing order data that includes data on Users’ medicines purchases or Users’ health, Wolt shall: (i) reasonably assist the Merchant in fulfilling its legal obligations under applicable data protection and healthcare laws; (ii) limit processing of order data on Users’ medicines purchases or Users’ health to what is necessary to provide the agreed Services and the Wolt Service to the Merchant and the Users, and to comply with any legal obligations; and (iii) to the extent OTC medicines are sold in the Wolt Service, implement a consent mechanism in the Wolt Service allowing Users to consent to the processing of their health data in context of orders containing medicines.